Related Experiment Video
Updated: Jun 7, 2025

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Prevalence, Management, and Outcomes of Non-Invasive Helicobacter pylori Testing in Children at a Tertiary Paediatric
Charanya Rajan1, Fang Kuan Chiou1, Christopher Wen Wei Ho1
1Division of Gastroenterology, Hepatology and Nutrition Service, Department of Paediatric Medicine, KK Women's and Children's Hospital, Singapore, Singapore.
Insights
Pediatric H. pylori testing often uses a test-and-treat approach, deviating from guidelines. This study found high treatment rates and varied outcomes in children undergoing non-invasive H. pylori diagnosis.
Area of Science:
- Pediatric Gastroenterology
- Infectious Diseases
- Clinical Practice Guidelines
Background:
- Helicobacter pylori infections present differently in pediatric versus adult populations.
- Current pediatric practice guidelines advise against a test-and-treat strategy for H. pylori diagnosis.
- Clinical practice often deviates from established guidelines, necessitating an examination of current approaches.
Purpose of the Study:
- To investigate the utilization of non-invasive H. pylori testing (stool antigen, urea breath test) in children.
- To analyze management decisions and patient outcomes following H. pylori diagnosis in a pediatric tertiary hospital.
- To assess adherence to clinical guidelines regarding H. pylori management in pediatric patients.
Main Methods:
- A retrospective review of pediatric patients (0-18 years) tested for H. pylori via stool antigen or urea breath test (UBT) from January 2018 to June 2020.
- Analysis of diagnostic test results, symptoms, treatment regimens, and symptom resolution.
- Comparison of testing and treatment strategies against existing pediatric practice guidelines.
Main Results:
- 1,397 children were tested; 8.4% had positive stool antigen tests and 5.9% had positive UBTs.
- Abdominal pain was the most common symptom (80.3%). Only 7 treatment-naïve children had biopsy-proven disease.
- 91.0% of children received treatment, with a common regimen of PPI, amoxicillin, and clarithromycin; 50.8% experienced symptom resolution.
Conclusions:
- A test-and-treat strategy was frequently employed, indicating low compliance with pediatric H. pylori management guidelines.
- Non-invasive testing in children revealed a notable rate of false positives.
- The study highlights discrepancies between recommended guidelines and actual clinical practice in diagnosing and treating H. pylori in pediatric populations.
Purpose:
Helicobacter pylori infections differ between children and adults. The Pediatric society practice guidelines recommend against a test-and-treat approach, characterized by the use of non-invasive tests for diagnosis (e.g. urea breath test [UBT] or stool antigen test). However, significant variations exist in clinical practice. This study examined the use of non-invasive testing for the screening and diagnosis of H. pylori infection in children at a tertiary pediatric hospital in Singapore, reviewing both management decisions and patient outcomes.
Methods:
A retrospective review was conducted on children between the ages of 0 and 18 years who were tested for H. pylori infection using either a stool antigen test or UBT between January 2018 and June 2020.
Results:
Among the 1,397 children tested, 117 (8.4%) had a positive stool H. pylori antigen result, and 5 out of 85 tested (5.9%) had a positive UBT. Abdominal pain was the predominant symptom (n=98; 80.3%). Only 7 treatment-naïve children had biopsy-proven disease. Tissue biopsies for H. pylori culture were sent to 2 children, with 1 negative result. A total of 111 children (91.0%) received treatment, wherein proton pump inhibitor, amoxicillin, and clarithromycin for 14 days was the most common therapeutic regimen. Symptom resolution was observed in 62 children (50.8%).
Conclusion:
A test-and-treat strategy was more widely utilized than endoscopy-based testing, showing a low compliance to existing guidelines for the management of H. pylori infections in children at our center and significant false-positive rates.
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease

